Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APIGENEX is an established CRO based in Prague, Czech Republic, providing high-quality services in drug discovery and preclinical development. The company specializes in medicinal chemistry, peptide synthesis, pharmacological models, pharmacokinetic/pharmacodynamic studies, custom synthesis of specialty chemicals and APIs under GMP/GLP standards. It has a long-standing partnership with Novo Nordisk focused on diabetes and obesity research. APIGENEX does not have its own clinical pipeline but supports clients' R&D programs from early discovery through preclinical stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APIGENEX s.r.o..